VanD-type resistance to glycopeptides in Enterococcus faecium
In gram-positive bacteria, glycopeptides inhibit the last steps of peptidoglycan synthesis by binding to the C-terminal dipeptide D-alanyl-D-alanine (D-Ala-D-Ala) of peptidoglycan precursors, thus preventing their incorporation into the cell wall (23) . Acquired resistance to vancomycin and teicoplanin in enterococci is due to the replacement of D-Ala-D-Ala by the depsipeptide D-alanyl-D-lactate (D-Ala-D-Lac). This substitution leads to the formation of modified peptidoglycan precursors for which glycopeptides exhibit 1,000-fold lower binding affinities (11) .
Two types of acquired resistance to glycopeptides have been well characterized (for a recent review, see reference 6). VanA-type enterococci display inducible resistance to high levels of both vancomycin and teicoplanin, whereas VanB-type enterococci display inducible resistance to various levels of vancomycin but remain susceptible to teicoplanin. In addition to the host D-Ala:D-Ala ligase (Ddl), a resistance ligase, VanA or VanB, mediates formation of D-Ala-D-Lac, which competes with D-Ala-D-Ala in cell wall assembly. Two other proteins are required for resistance: VanH (VanH B ), a dehydrogenase which converts pyruvate into D-Lac (11) , and VanX (VanX B ), a DD-dipeptidase which hydrolyzes D-Ala-D-Ala produced by the chromosomal Ddl (24) . VanY (VanY B ), inessential for resistance, is a DD-carboxypeptidase which acts when significant incorporation of D-Ala-D-Ala occurs in spite of VanX hydrolysis. Under such conditions, VanY hydrolyzes pentapeptides and, to a lesser extent, pentadepsipeptides (1a) . Thus, two DD-peptidases, VanX (VanX B ) and VanY (VanY B ), contribute sequentially to resistance in reducing the pool of pentapeptide precursors, favoring their replacement by pentadepsipeptides in cell wall assembly. Two proteins which belong to the family of two-component regulatory systems control the level of expression of the resistance genes in response to the presence of glycopeptides in the culture medium. The VanS (VanS B ) sensor governs phosphorylation of the regulator VanR (VanR B ), which acts as a transcriptional activator for the resistance genes. An accessory protein other than VanY, VanZ, has also been identified in VanA-type strains. VanZ confers low-level teicoplanin resistance by an unknown mechanism. The open reading frame (ORF) vanW is present in the vanB operon, but no function has yet been assigned to the corresponding protein (14) .
A new type of acquired resistance to glycopeptides, VanD, was recently found in Enterococcus faecium BM4339 (22) and in other E. faecium strains (19) . Clinical isolate BM4339 is resistant to intermediate levels of vancomycin (MIC ϭ 64 g/ ml) and to low levels of teicoplanin (MIC ϭ 4 g/ml) and does not harbor the vanA or vanB operon. Glycopeptide resistance in this strain is constitutively expressed and mediated by synthesis of pentadepsipeptide precursors ending in D-Ala-D-Lac, which represent the main components of cell wall cytoplasmic precursors (22) .
In this work, we describe the genetic organization of the vanD gene cluster in E. faecium BM4339. We also show that a frameshift mutation in the chromosomal ddl gene accounts for the lack of precursors terminating in D-Ala-D-Ala in this strain.
MATERIALS AND METHODS
Strains, plasmids, and growth conditions. The bacterial strains and plasmids used are described in Table 1 . Unless specified, Escherichia coli JM83 (35) and E. coli TB1 (Focus, Life Technologies Inc., Gaithersburg, Md.) were used as the hosts in cloning experiments. Bacteria were cultured in brain heart infusion broth or agar (Difco Laboratories, Detroit, Mich.) at 37°C. The method of Steers et al. Recombinant DNA techniques. Plasmid DNA isolation, cleavage of DNA with restriction endonucleases (Amersham, Little Chalfont, Buckinghamshire, England; Gibco BRL-Life Technologies Inc.; and Pharmacia, Uppsala, Sweden), purification of restriction fragments from agarose gel, dephosphorylation of vector DNA with calf intestinal phosphatase (Pharmacia), and ligation with T4 DNA ligase (Pharmacia) were performed by standard methods (26) .
Plasmid construction. The plasmids were constructed as explained below (Fig.  1) .
(i) Plasmid pAT654. E. faecium BM4339 total DNA was partially digested with Sau3AI and ligated with pUC18 DNA cleaved by BamHI. To identify recombinant plasmids, clones were screened by colony hybridization (26) with the 605-bp fragment internal to vanD purified from pAT656 (22) as a probe (Fig. 1) .
(ii) Plasmid pAT657. To amplify a fragment internal to the vanR D and the vanS D genes, the degenerate oligodeoxynucleotide VR (1) was used in combination with the specific primer SD (5Ј GTTCTTCCAGACGCTCA), complementary to the 5Ј end of the insert in pAT654. Oligodeoxynucleotide VR [5Ј GGIGCIGA(T/C)GA(T/C)TA(T/C)ITIIIIAA(A/G)CCITT, where I is deoxyinosine] was deduced from the sequences of conserved motifs located in the C termini of the effector domains of VanR, OmpR, and PhoB response regulators (5) . The PCR product obtained with BM4339 total DNA as a template and Taq DNA polymerase (U.S. Biochemical-Amersham) was cloned into pCR2.1 (Invitrogen, Carlsbad, Calif.) and introduced into E. coli INV␣FЈ (Invitrogen) by transformation.
(iii) Plasmid pAT658. To complete the sequence of the vanR D gene, total DNA from E. faecium BM4339 was digested with EcoRI and ClaI, HindIII and ClaI, EcoRI and SspI, and HindIII and SspI, and the sizes of the fragments hybridizing with a 271-bp probe corresponding to the 5Ј end of the pAT657 insert ( Fig. 1) were estimated (26) . Cloning was performed with restriction endonucleases generating fragments of more than 1 kb in length. The recombinant plasmids were screened by hybridization with the same probe, and plasmid pAT658, selected for further studies, contained a 1.8-kb HindIII-ClaI insert.
(iv) Plasmid pAT661. A strategy similar to that used with plasmid pAT658 was followed to clone the chromosomal ddl gene from BM4339. The 600-bp fragment internal to the E. faecium BM4147 ddl gene (13) Nucleotide sequence accession numbers. The 5,781-bp fragment containing the vanD gene cluster was submitted to GenBank and assigned accession no. AF130997. The nucleotide sequence of the 1,240-bp chromosomal region containing the BM4339 ddl gene was allotted accession no. AF130998.
RESULTS AND DISCUSSION
Identification of the van genes and protein sequence analysis. Partial digests of E. faecium BM4339 total DNA were cloned into E. coli, and transformants were screened by hybridization with a vanD internal probe (Fig. 1) . Plasmid pAT654 (vanS D Ј vanY D H D DX D ) carried an insert of 5.3 kb that was sequenced with specific primers. Analysis of the sequence revealed five ORFs with the same orientation, the 5Ј one being truncated (Fig. 1) . The deduced amino acid sequences were compared to those of the proteins encoded by the vanA and vanB operons ( (34) , and with PBP 6 from E. coli (9) . VanY D contained in the right order the motifs predicted to define the active sites of these PBPs (20) : SXXK, which includes the catalytic serine, the SG(C/N) triad, and the KTG motif (Fig. 2) . Consistent with these observations, the DD-carboxypeptidase activity detected in BM4339 was sensitive to penicillin G (22), unlike the activities of VanY (4) and VanY B (14) . A PCR strategy was used to complete the sequence of vanS D . Since the gene organization in BM4339 was similar to those of the vanA and vanB clusters (6) , an ORF related to vanR and vanR B was expected to be located upstream from vanS D . In two-component regulatory systems, response regulators display well-conserved N-terminal domains (15) . Based on the alignment of VanR, OmpR, and PhoB (5), the degenerate oligodeoxynucleotide VR was designed and used in combination with primer SD, specific for vanS D (Fig. 1) . A product with the 1-kb expected size was obtained and cloned. Recombinant plasmid pAT657 (vanR D ЈS D Ј) contained the 5Ј missing portion of vanS D and the 3Ј half of the vanR D gene (Fig. 1) . To recover the 5Ј extremity of vanR D , total DNA from BM4339 was digested and cloned into E. coli and transformants were (14) . No genes homologous to vanZ and vanW from the vanA and vanB operons, respectively, were found. Cloning and sequence analysis of the E. faecium BM4339 ddl gene. The insert in recombinant plasmid pAT661 (ddl BM4339) ( Table 1) was sequenced on 1,300 consecutive base pairs with divergent primers complementary to the termini of the 600-bp fragment internal to the BM4147 ddl gene (13) and specific oligodeoxynucleotides. In turn, the sequence of the BM4339 ddl region allowed the cloning by PCR of the entire BM4147 ddl gene (14a). Comparison of the two ddl sequences revealed the presence of a 5-bp insertion near the 5Ј end in the BM4339 gene (Fig. 3) . The insertion was responsible for a frameshift leading to the synthesis of a 26-amino-acid peptide instead of the putative 358-amino-acid Ddl. Production of a truncated protein accounts for the lack of D-Ala-D-Ala-containing peptidoglycan precursors in BM4339 (22) . VanA-type (25, 29) and VanB-type (7, 32) mutants of Enterococcus impaired in Ddl activity grow only in the presence of glycopeptides. These antibiotics are required to induce production of the resistance ligase and dehydrogenase and, therefore, to synthesize peptidoglycan from D-Ala-D-Lac-instead of D-Ala-DAla-containing precursors. In E. faecium BM4339, constitutive expression of glycopeptide resistance (22) accounts for the fact that this strain is not glycopeptide dependent.
trans complementation of the insertional mutation in the BM4339 ddl gene. The ddl gene from E. faecium BM4147 was cloned under the control of the heterologous enterococcal P 2 promoter in the gram-positive expression vector pAT79 (5), leading to pAT662 (ddl BM4147) ( Table 1 ). The recombinant plasmid was introduced by electrotransformation into E. faecium BM4339, and transformants, such as BM4409 (Table 1) , were susceptible to vancomycin and teicoplanin (MICs ϭ 0.5 g/ml). The decrease in glycopeptide resistance was most likely due to expression of the heterologous Ddl since no VanX DD-dipeptidase activity is present in cytoplasmic extracts from E. faecium BM4339 and only low levels of VanY DD-carboxypeptidase activity are found in membrane preparations (22) .
Peculiarities of VanD-type glycopeptide resistance in E. faecium BM4339. Inducible expression of the resistance genes in VanA-and VanB-type strains is regulated by the two-component systems VanRS and VanR B S B , respectively. VanB-type constitutive variants harbor mutations in the vanS B sensor gene (7) that are thought to impair dephosphorylation of the VanR B regulator (2, 7). The sequences of VanR D and VanS D were analyzed for the presence of the amino acids involved in protein phosphorylation and of the motifs conserved in response regulators and protein kinases (21) . The three amino acids Asp10, Asp53 (which corresponds to the putative site of phosphorylation), and Lys101, highly conserved in the effector domains of response regulators (21) , were present in VanR D (data not shown). The five motifs characteristic of protein kinases (21) , namely, H (positions 164 to 172), N (273 to 284), G1 (309 to 317), F (324 to 328), and G2 (340 to 346), including the histidine at position 166, which is the putative site of autophosphorylation (data not shown), were found in VanS D . The constitutive phenotype of BM4339 may be due to mutations located near the putative autophosphorylation site and known to alter the phosphatase activity of VanS B (7) . Alternatively, the signal recognition properties of VanS D may be impaired, leading to phosphorylation of VanR D even in the absence of glycopeptides. Another possibility is that alternate phosphorylation of VanR D by acetyl phosphate or by a heterologous protein kinase (2) maintains high concentrations of VanR D -phosphate in spite of VanS D phosphatase activity.
As already mentioned, insertional inactivation of the BM4339 chromosomal ddl gene accounts for the absence of D-Ala-D-Ala-containing peptidoglycan precursors in this strain (22) . Lack of a substrate for DD-dipeptidase hydrolysis makes VanX D superfluous in achieving glycopeptide resistance in BM4339. As a matter of fact, although VanX D does not exhibit mutations in the conserved residues involved in zinc binding and catalysis (17) (data not shown), BM4339 does not produce DD-dipeptidase activity (22) . It has been shown that a mutation in the host ddl gene can compensate for inactivation of vanX in VanA-type strains (1a) . Conversely, loss of production of VanX D DD-dipeptidase activity in BM4339 may be secondary to the impairment of the host ligase.
The VanY D DD-carboxypeptidase exhibited the same hydro- phobicity profile as VanY (4) and VanY B (14) , with a cluster of hydrophobic residues near the N terminus of the protein (data not shown). VanY D may thus be a membrane-anchored protein that acts like VanY and VanY B . The DD-carboxypeptidase contributes to resistance by hydrolyzing precursors containing the D-Ala-D-Ala target of glycopeptides (1a, 3) . This activity in BM4339 may explain the presence of tetrapeptide peptidoglycan precursors (17% of the precursors synthesized [22] ). In this strain, the substrates for the DD-carboxypeptidase may be the pentapeptides (which represent only 2% of all precursors [22] ) and, to a minor extent, the pentadepsipeptides. The pentapeptide precursors may conceivably originate from a very low rate of production of D-Ala-D-Ala by VanD. Like VanA (10) and VanB (18) , the related VanD ligase may display broad substrate specificity, leading to synthesis of D-Ala-D-Ala at a level lower than that of D-Ala-D-Lac but in sufficient amount to require a weak contribution of VanY D DD-carboxypeptidase activity.
In conclusion, E. faecium BM4339 harbors the vanD gene cluster responsible for glycopeptide resistance. The D-Ala:DAla ligase in this strain is not functional following a mutation in the chromosomal ddl gene. However, replacement of the host metabolic pathway for synthesis of D-Ala-ending peptidoglycan precursors by the constitutively expressed resistance pathway leading to production of D-Lac-terminating precursors allows glycopeptide-independent growth of BM4339.
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